No profile data available.
Biohaven Ltd. (BHVN) is a healthcare company in the brain and nerve treatment drugs industry, based in New Haven, United States, with about 274 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$738.82 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $1.82 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for immunology, neuroscience, and oncology therapeutic areas worldwide.
Biohaven reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$1.82 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Supernus Pharmaceuticals, Inc. (SUPN), Harmony Biosciences Holdings, Inc. (HRMY), Sarepta Therapeutics, Inc. (SRPT), Compass Pathways plc (CMPS).